Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

721 recalls, newest first

Class II · Moderate risk

Lacosamide Tablets

CGMP Deviations

Ongoing cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-679-60 D-0330-2025
Class II · Moderate risk

chlorproMAZINE Hydrochloride Tablets

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Ongoing Nitrosamine impurity Glenmark Pharmaceuticals Inc., USA NDC 68462-864-01 D-0309-2025

Recalls by year